New re­port her­alds a rev­o­lu­tion in can­cer R&D trends - and the stick­er shock that comes with it

There’s a rev­o­lu­tion play­ing out in can­cer R&D.

Over the last decade drug de­vel­op­ers fo­cused on on­col­o­gy have teamed with reg­u­la­tors on de­sign­ing a short­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.